Surmodics Stock Cash And Equivalents

SRDX Stock

USD 39.56 0.23 0.58%

SurModics fundamentals help investors to digest information that contributes to SurModics' financial success or failures. It also enables traders to predict the movement of SurModics Stock. The fundamental analysis module provides a way to measure SurModics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SurModics stock.

Other Current Liab Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

SurModics Company Cash And Equivalents Analysis

SurModics' Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Cash

Bank Deposits

+

Liquidities

More About Cash And Equivalents | All Equity Analysis

Current SurModics Cash And Equivalents

22.09 M

Most of SurModics' fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SurModics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

SurModics Cash And Equivalents Driver Correlations

Understanding the fundamental principles of building solid financial models for SurModics is extremely important. It helps to project a fair market value of SurModics Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since SurModics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of SurModics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of SurModics' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Investments	Common Stock	Property Plant Equipment	Current Deferred Revenue	Intangible Assets	Short Term Debt	Long Term Debt	Good Will	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.93	0.03	0.74	0.79	0.83	0.85	0.87	0.24	0.64	0.93	0.64	0.75	0.14	0.7	0.79	-0.78	-0.35	0.68	-0.75	0.8	-0.33	0.08	0.42
Total Stockholder Equity	0.93		-0.19	0.89	0.61	0.66	0.66	0.84	0.26	0.78	0.81	0.46	0.57	0.05	0.6	0.56	-0.66	-0.61	0.5	-0.69	0.66	-0.19	0.13	0.36
Net Debt	0.03	-0.19		-0.48	0.38	0.25	0.38	-0.33	-0.13	-0.3	0.18	0.04	0.41	0.28	0.3	0.44	-0.26	0.61	0.15	0.18	0.34	-0.14	-0.15	0.46
Retained Earnings	0.74	0.89	-0.48		0.4	0.38	0.33	0.74	0.41	0.85	0.56	0.37	0.33	0.08	0.25	0.26	-0.45	-0.81	0.28	-0.54	0.36	-0.19	0.01	-0.05
Accounts Payable	0.79	0.61	0.38	0.4		0.75	0.81	0.63	0.18	0.48	0.78	0.52	0.71	0.22	0.55	0.77	-0.86	-0.11	0.46	-0.63	0.78	-0.35	-0.13	0.43
Net Receivables	0.83	0.66	0.25	0.38	0.75		0.81	0.65	-0.21	0.38	0.78	0.5	0.78	0.28	0.87	0.88	-0.75	0.08	0.69	-0.62	0.74	-0.54	-0.08	0.54
Total Liab	0.85	0.66	0.38	0.33	0.81	0.81		0.67	0.08	0.27	0.91	0.68	0.8	0.14	0.78	0.86	-0.77	0.0	0.73	-0.71	0.9	-0.27	0.05	0.72
Total Current Assets	0.87	0.84	-0.33	0.74	0.63	0.65	0.67		0.34	0.59	0.81	0.62	0.46	-0.16	0.53	0.56	-0.58	-0.47	0.59	-0.81	0.66	-0.1	0.31	0.21
Short Term Investments	0.24	0.26	-0.13	0.41	0.18	-0.21	0.08	0.34		0.18	0.33	0.47	0.04	-0.05	-0.2	0.01	0.1	-0.35	0.25	-0.23	0.25	0.27	0.22	-0.4
Common Stock	0.64	0.78	-0.3	0.85	0.48	0.38	0.27	0.59	0.18		0.39	0.24	0.21	-0.02	0.2	0.16	-0.54	-0.73	0.1	-0.28	0.2	-0.29	-0.08	-0.01
Property Plant Equipment	0.93	0.81	0.18	0.56	0.78	0.78	0.91	0.81	0.33	0.39		0.74	0.74	0.14	0.77	0.81	-0.66	-0.18	0.81	-0.79	0.94	-0.16	0.12	0.52
Current Deferred Revenue	0.64	0.46	0.04	0.37	0.52	0.5	0.68	0.62	0.47	0.24	0.74		0.45	0.08	0.47	0.51	-0.27	-0.03	0.87	-0.5	0.66	-0.27	-0.03	0.15
Intangible Assets	0.75	0.57	0.41	0.33	0.71	0.78	0.8	0.46	0.04	0.21	0.74	0.45		0.64	0.62	0.95	-0.75	0.12	0.58	-0.64	0.71	-0.58	-0.27	0.44
Short Term Debt	0.14	0.05	0.28	0.08	0.22	0.28	0.14	-0.16	-0.05	-0.02	0.14	0.08	0.64		0.1	0.45	-0.27	0.23	0.16	-0.18	0.12	-0.67	-0.78	-0.06
Long Term Debt	0.7	0.6	0.3	0.25	0.55	0.87	0.78	0.53	-0.2	0.2	0.77	0.47	0.62	0.1		0.75	-0.49	0.16	0.73	-0.55	0.78	-0.26	0.16	0.72
Good Will	0.79	0.56	0.44	0.26	0.77	0.88	0.86	0.56	0.01	0.16	0.81	0.51	0.95	0.45	0.75		-0.74	0.22	0.69	-0.67	0.8	-0.49	-0.1	0.5
Net Tangible Assets	-0.78	-0.66	-0.26	-0.45	-0.86	-0.75	-0.77	-0.58	0.1	-0.54	-0.66	-0.27	-0.75	-0.27	-0.49	-0.74		0.26	-0.26	0.63	-0.6	0.38	0.2	-0.52
Capital Surpluse	-0.35	-0.61	0.61	-0.81	-0.11	0.08	0.0	-0.47	-0.35	-0.73	-0.18	-0.03	0.12	0.23	0.16	0.22	0.26		0.18	0.29	-0.01	-0.2	-0.08	0.12
Deferred Long Term Liab	0.68	0.5	0.15	0.28	0.46	0.69	0.73	0.59	0.25	0.1	0.81	0.87	0.58	0.16	0.73	0.69	-0.26	0.18		-0.5	0.75	-0.27	0.07	0.32
Long Term Investments	-0.75	-0.69	0.18	-0.54	-0.63	-0.62	-0.71	-0.81	-0.23	-0.28	-0.79	-0.5	-0.64	-0.18	-0.55	-0.67	0.63	0.29	-0.5		-0.72	0.14	-0.07	-0.4
Short Long Term Debt	0.8	0.66	0.34	0.36	0.78	0.74	0.9	0.66	0.25	0.2	0.94	0.66	0.71	0.12	0.78	0.8	-0.6	-0.01	0.75	-0.72		-0.15	0.1	0.62
Net Invested Capital	-0.33	-0.19	-0.14	-0.19	-0.35	-0.54	-0.27	-0.1	0.27	-0.29	-0.16	-0.27	-0.58	-0.67	-0.26	-0.49	0.38	-0.2	-0.27	0.14	-0.15		0.61	0.01
Net Working Capital	0.08	0.13	-0.15	0.01	-0.13	-0.08	0.05	0.31	0.22	-0.08	0.12	-0.03	-0.27	-0.78	0.16	-0.1	0.2	-0.08	0.07	-0.07	0.1	0.61		0.12
Capital Stock	0.42	0.36	0.46	-0.05	0.43	0.54	0.72	0.21	-0.4	-0.01	0.52	0.15	0.44	-0.06	0.72	0.5	-0.52	0.12	0.32	-0.4	0.62	0.01	0.12

Click cells to compare fundamentals

Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).

Competition

Predict SurModics

SurModics Cash And Cash Equivalents Changes

Cash And Cash Equivalents Changes

(9.72 Million)

SurModics reported Cash And Cash Equivalents Changes of (10.23 Million) in 2023

In accordance with the recently published financial statements, SurModics has 22.09 M in Cash And Equivalents. This is 97.31% lower than that of the Health Care Equipment & Supplies sector and 96.04% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 99.18% higher than that of the company.

SurModics Cash And Equivalents Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SurModics' direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SurModics could also be used in its relative valuation, which is a method of valuing SurModics by comparing valuation metrics of similar companies.

SurModics is currently under evaluation in cash and equivalents category among its peers.

SurModics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, SurModics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to SurModics' managers, analysts, and investors.

Environmental

Governance

Social

SurModics Fundamentals

	Return On Equity	-0.0967
	Return On Asset	-0.0066
	Profit Margin	(0.09) %
	Operating Margin	(0.02) %
	Current Valuation	556.57 M
	Shares Outstanding	14.33 M
	Shares Owned By Insiders	3.79 %
	Shares Owned By Institutions	83.07 %
	Number Of Shares Shorted	330.95 K
	Price To Earning	69.21 X
	Price To Book	4.74 X
	Price To Sales	4.47 X
	Revenue	126.08 M
	Gross Profit	29 M
	EBITDA	1.19 M
	Net Income	(11.54 M)
	Cash And Equivalents	22.09 M
	Cash Per Share	1.58 X
	Total Debt	29.55 M
	Debt To Equity	0.12 %
	Current Ratio	2.04 X
	Book Value Per Share	8.38 X
	Cash Flow From Operations	248 K
	Short Ratio	1.51 X
	Earnings Per Share	(0.82) X
	Price To Earnings To Growth	3.90 X
	Target Price	43.0
	Beta	1.2
	Market Capitalization	563.44 M
	Total Asset	178.56 M
	Retained Earnings	75.71 M
	Working Capital	60.76 M
	Current Asset	58.56 M
	Current Liabilities	10.13 M
	Net Asset	178.56 M

About SurModics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze SurModics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SurModics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SurModics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for SurModics Stock Analysis

When running SurModics' price analysis, check to measure SurModics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SurModics is operating at the current time. Most of SurModics' value examination focuses on studying past and present price action to predict the probability of SurModics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SurModics' price. Additionally, you may evaluate how the addition of SurModics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC